Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03926013
Title A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

prostate adenocarcinoma

renal cell carcinoma

Therapies

JNJ-63898081

Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94158 United States Details
NIH Clinical Center Bethesda Maryland 20892 United States Details
Columbia University Medical Center New York New York 10032 United States Details
University of Utah Salt Lake City Utah 84112 United States Details
University of Washington Seattle Washington 98195-9472 United States Details
British Columbia Cancer Agency Vancouver British Columbia V5Z4E6 Canada Details
Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field